Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Juli 2024

Biotek-snakken — Juli 2024

Planlagt Fastgjort Låst Flyttet Biotek-snakken
94 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #33

    BioArctic's Partner Eisai Says Leqembi Approved In Hong Kong For Alzheimer's Disease Treatment https://proinvestor.com/investornyt/1183677/bioarctics-partner-eisai-says-leqembi-approved-in-hong-kong-for-alzheimers-disease-treatment

    1 Reply Last reply
    0
    • L Offline
      L Offline
      LP90
      wrote on sidst redigeret af
      #34

      Godmorgen 🙂

      1 Reply Last reply
      0
      • exitnuE Offline
        exitnuE Offline
        exitnu
        wrote on sidst redigeret af
        #35

        God morgen 🙂

        1 Reply Last reply
        0
        • exitnuE Offline
          exitnuE Offline
          exitnu
          wrote on sidst redigeret af
          #36

          ASCELIA PHARMA CARRIES OUT A RIGHTS ISSUE OF UNITS OF APPROXIMATELY SEK 105 MILLION TO FULLY FINANCE THE NDA SUBMISSION FOR ORVIGLANCE®

          https://www.ascelia.com/mfn_news/ascelia-pharma-carries-out-a-rights-issue-of-units-of-approximately-sek-105-million-to-fully-finance-the-nda-submission-for-orviglance/

          1 Reply Last reply
          0
          • exitnuE Offline
            exitnuE Offline
            exitnu
            wrote on sidst redigeret af
            #37

            Ascelia: Proceeds with a SEK 105m rights issue of units

            https://www.redeye.se/research/1021278/ascelia-proceeds-with-a-sek-105m-rights-issue-of-units

            1 Reply Last reply
            0
            • exitnuE Offline
              exitnuE Offline
              exitnu
              wrote on sidst redigeret af
              #38

              " ... We regard this initiative as positive. Ascelia will be in a strong position to negotiate terms with a US partner, and the funding will dramatically reduce the financial uncertainty in Ascelia. The proposed funding will also allow Ascelia to focus on securing FDA approval for Orviglance and securing a US commercial partner on favourable terms."

              1 Reply Last reply
              0
              • Z Offline
                Z Offline
                Zambo
                wrote on sidst redigeret af
                #39

                Ascelia Pharma: Trist udvikling på kursen siden fase 3 udmelding. Kunne det ikke være meldt mere klart ud hvad kursen på emission ville være

                1 Reply Last reply
                0
                • exitnuE Offline
                  exitnuE Offline
                  exitnu
                  wrote on sidst redigeret af
                  #40

                  33.757.746 aktier x kurs ca. 6 = pt. børsværdi 202 MSEK 🙂

                  Læs d.d. RESEARCH NOTE fra Redeye!

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    ProinvestorNEWS
                    wrote on sidst redigeret af
                    #41

                    BioArctic : Eisai's Leqembi Approved In Israel For Alzheimer's Disease Treatment https://proinvestor.com/investornyt/1184229/bioarctic-eisais-leqembi-approved-in-israel-for-alzheimers-disease-treatment

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #42

                      Immutep's Eftilagimod Alfa Combination Shows Positive Phase IIb Results In Head & Neck Cancer Trial https://proinvestor.com/investornyt/1184225/immuteps-eftilagimod-alfa-combination-shows-positive-phase-iib-results-in-head-amp-neck-cancer-trial

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #43

                        15 Healthcare Stocks Hit New Highs: Did You Spot These Winners? https://proinvestor.com/investornyt/1184904/15-healthcare-stocks-hit-new-highs-did-you-spot-these-winners

                        1 Reply Last reply
                        0
                        • F Offline
                          F Offline
                          Fandel
                          wrote on sidst redigeret af
                          #44

                          Godmorgen...

                          1 Reply Last reply
                          0
                          • L Offline
                            L Offline
                            LP90
                            wrote on sidst redigeret af
                            #45

                            Godmorgen 🙂

                            1 Reply Last reply
                            0
                            • J Offline
                              J Offline
                              Jazzz
                              wrote on sidst redigeret af
                              #46

                              https://storage.mfn.se/7a455d65-f919-4ef8-b60b-b1ff5bb5dfe0/acarix-receives-sizeable-patch-reorder-from-louisiana-primary-care-clinic.pdf

                              1 Reply Last reply
                              0
                              • J Offline
                                J Offline
                                Jazzz
                                wrote on sidst redigeret af
                                #47

                                Acarix

                                1 Reply Last reply
                                0
                                • J Offline
                                  J Offline
                                  Jazzz
                                  wrote on sidst redigeret af
                                  #48

                                  Just a moment...

                                  favicon

                                  (www.acarix.com)

                                  1 Reply Last reply
                                  0
                                  • J Offline
                                    J Offline
                                    Jazzz
                                    wrote on sidst redigeret af
                                    #49

                                    3.og sidste gode nyhed.. https://www.acarix.com/news/press/acarix-shares-begin-trading-on-the-us-based-otcqb-market

                                    1 Reply Last reply
                                    0
                                    • A Offline
                                      A Offline
                                      Aps_invest
                                      wrote on sidst redigeret af
                                      #50

                                      Og kunne Acarix så også lige få flere store ordrer, så bliver “lodsedlen” sjov, Jazz…
                                      spændende 🙂

                                      1 Reply Last reply
                                      0
                                      • A Offline
                                        A Offline
                                        Aps_invest
                                        wrote on sidst redigeret af
                                        #51

                                        Ihvertfald ikke nu man skal sælge, hvor tingene begynder for alvor at tage fart. Men heller ikke en aktie man skal smide for mange penge efter, før vi ser endnu flere gode nyheder der bekræfter gennembruddet.

                                        1 Reply Last reply
                                        0
                                        • F Offline
                                          F Offline
                                          Fandel
                                          wrote on sidst redigeret af
                                          #52

                                          Godmorgen...

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper